1.26
10.64%
-0.15
시간 외 거래:
1.26
전일 마감가:
$1.41
열려 있는:
$1.38
하루 거래량:
146.00K
Relative Volume:
0.56
시가총액:
$2.89M
수익:
$502.40K
순이익/손실:
$-7.91M
주가수익비율:
-0.7746
EPS:
-1.6266
순현금흐름:
$-4.32M
1주 성능:
-10.64%
1개월 성능:
+36.96%
6개월 성능:
-61.82%
1년 성능:
-91.03%
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
명칭
60 Degrees Pharmaceuticals Inc
전화
202-327-5422
주소
1025 CONNECTICUT AVENUE NW, WASHINGTON
SXTP을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.26 | 2.89M | 502.40K | -7.91M | -4.32M | -9.972 |
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스
Insider Buying: Cheryl Xu Acquires 13,000 Shares of 60 Degrees P - GuruFocus.com
60 degrees pharmaceuticals director Cheryl Xu acquires $21,400 in stock - Investing.com India
60 degrees pharmaceuticals director Cheryl Xu acquires $21,400 in stock By Investing.com - Investing.com Australia
60 Degrees Pharmaceuticals (NASDAQ:SXTP) Earns “Neutral” Rating from HC Wainwright - Defense World
60 Degrees Pharma shares stay Neutral amid progress on Arakoda trial - Investing.com
60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women's Hospital - The Manila Times
60 Degrees Pharmaceuticals launches babesiosis drug trial - Investing.com
60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital - GlobeNewswire
60 Degrees Pharma Expands Promising Babesiosis Treatment Trial to Brigham & Women's Hospital - StockTitan
Why Stitch Fix Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga
Pre-market Movers: CMRX, CPIX, PCSA, CRDF, VRAR… - RTTNews
60 degrees pharmaceuticals CEO Geoffrey Dow acquires $89,755 in stock By Investing.com - Investing.com UK
cbdMD (AMEX:YCBD) Stock Quotes, Forecast and News Summary - Benzinga
VSee Health CEO Reveals AI Platform's 1.5M Monthly Telehealth Encounters on Bloomberg TV | SXTP Stock News - StockTitan
VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
VSee Health CEO Reveals AI Platform's 1.5M Monthly Telehealth Encounters on Bloomberg TV | VSEE Stock News - StockTitan
60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
60 Degrees & Can-Fite CEOs to Showcase Drug Pipeline on Bloomberg TV | SXTP Stock News - StockTitan
60 degrees pharmaceuticals CEO Geoffrey Dow acquires $6,367 in stock - Investing.com India
60 Degrees Pharmaceuticals’ (SXTP) Neutral Rating Reaffirmed at HC Wainwright - Defense World
60 Degrees Pharmaceuticals Inc. (SXTP) Reports Q3 Loss, Misses Revenue Estimates - MSN
60 Degrees Pharmaceuticals Reports 164% Sales Surge in Q3 2024, Driven by ARAKODA® Growth - GuruFocus.com
ARMISTICE CAPITAL, LLC Acquires New Stake in 60 Degrees Pharmace - GuruFocus.com
60 Degrees Pharmaceuticals Inc. Warrant (SXTPW) Quarterly 10-Q Report - Quartzy
HALO Stock Dips 5.77% Amid Biotech Sector Changes - GuruFocus.com
60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results - Marketscreener.com
60 Degrees Pharma Reports 164% Revenue Surge, Doubles ARAKODA® Deliveries in Q3 | SXTP Stock News - StockTitan
OptiNose (OPTN) Reports Break-Even Earnings for Q3 - Nasdaq
60 Degrees Pharmaceuticals secures shareholder nods for key proposals - Investing.com India
60 Degrees Pharmaceuticals secures shareholder nods for key proposals By Investing.com - Investing.com South Africa
Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Compugen (CGEN) Stock Surges Amidst Biotech Sector Volatility - GuruFocus.com
TNF Pharmaceuticals (NASDAQ:TNFA) Stock Quotes, Forecast and News Summary - Benzinga
Hepion Pharmaceuticals (NASDAQ:HEPA) Stock Quotes, Forecast and News Summary - Benzinga
Interview with the President and CEO: 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) - The Wall Street Transcript
SEC Form DEF 14A filed by 60 Degrees Pharmaceuticals Inc. - Quantisnow
Allovir (ALVR) Stock Experiences Significant Decline Amid Negati - GuruFocus.com
Why Is Infection Treatment Focused-60 Degrees Pharmaceuticals Stock Soaring Today? - MSN
SXTP stock plunges to 52-week low, touches $1 mark By Investing.com - Investing.com UK
Why Are 60 Degrees Pharmaceuticals Shares Up By 50% Today? - MSN
60 Degrees Pharmaceuticals Outlines Plans For Rare Tick-Borne Infection Trial Evaluating Its Malaria Drug - MSN
60 Degrees Pharmaceuticals launches Arakoda promotional pilot - TipRanks
60 Degrees Pharmaceuticals pilots ARAKODA awareness program By Investing.com - Investing.com South Africa
60 Degrees Pharmaceuticals pilots ARAKODA awareness program - Investing.com
SXTP stock plunges to 52-week low, touches 1.01 USD By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch - The Manila Times
Del Taco Leads the Value Pack with New Del's Mucho Meal$™ and the Return of Cookie Butter Shake! - The Manila Times
Form PRE 14A 60 DEGREES PHARMACEUTICA For: Oct 02 - StreetInsider.com
K-pop group Fifty Fifty off to strong start with member line-up reboot - The Straits Times
Documented Gang Member Sentenced to Life in Prison for Killing Five People - Harris County District Attorney's Office
Ultraviolette set to export F77 sports bikes to European countries - Business Upturn
60 Degrees Pharmaceuticals Inc (SXTP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
60 Degrees Pharmaceuticals Inc 주식 (SXTP) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
XU CHERYL | Director |
Aug 27 '24 |
Buy |
1.70 |
5,000 |
8,500 |
41,078 |
XU CHERYL | Director |
May 16 '24 |
Option Exercise |
0.22 |
2,000 |
446 |
228,934 |
자본화:
|
볼륨(24시간):